🏛️ Verified NIH Record • Updated 2025-07-23

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada (NCT07095192)

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada: A Multilevel Implementation Science Study of Clinical Processes, Barriers, Facilitators and Implementation Strategies

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: McGill University

🩺 Plain-English Summary (8th-Grade Level)

The SCALE-POCT study is a national initiative designed to provide robust evidence for scaling up point-of-care hepatitis C testing for key populations. The study seeks to map current hepatitis C clinical processes, identify barriers and facilitators to implementation, and co-design practical tools and strategies in partnership with stakeholders. A major obstacle to hepatitis C elimination and increasing treatment uptake is the current multi-step diagnostic process, which leads to loss to follow-up and treatment delays, particularly among high-risk groups such as people who inject drugs. Point of-care hepatitis C antibody tests (results: 5-20 mins) and RNA tests (results: 60 mins), could enable single-visit diagnosis, reducing loss to follow-up. However, integrating these tests into key settings presents challenges. The overarching goal of this study is to generate evidence to inform the scale-up point-of-care hepatitis C testing and treatment in key settings in Canada. This study is observational in nature and does not involve the direct implementation of point-of-care hepatitis C testing. Instead, it aims to understand the contextual, procedural, and operational factors that would support its successful adoption and sustainability. By examining existing care models and engaging with key stakeholders, the study seeks to build a foundation for future implementation efforts. Specific objectives include: 1. Map current hepatitis C care processes and explore how point-of-care testing could fit into these models; 2. Identify barriers and facilitators to implementing point-of-care hepatitis C testing across settings and provinces; 3. Co-design tools and strategies (such as training guides, standard procedures) to support point-of-care testing; 4. Assess feasibility, acceptability, and costs of the co-designed tools and strategies.

Who can join: Review the eligibility criteria below.

Location: Anonyme L'Unite D'Intervention — Montreal, Quebec

Age range: 18 Years

🧪 Interventions in This Study

  • Preimplementation of HCV Point of care testing (OTHER)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (12 Sites)

  • Anonyme L'Unite D'Intervention — Montreal, Quebec
  • McGill University — Montreal, Quebec
  • Indigenous Health Centre of Tiohtià:ke — Montreal, Quebec
  • L'Anonyme — Montreal, Quebec
  • Centre de réadaptation en dépendance de Québec (CRDQ) — Québec, Quebec
  • Medicins du Monde — Montreal,
  • Okanagan prison — Okanagan,
  • SABSA Cooperative — Québec,
  • Sioux Lookout First Nation Health Authority — Sioux Lookout,
  • Ontario - Provincial correction — Toronto,
  • Rapid Access Addiction Clinic St Paul's Hospital — Vancouver,
  • Maamwesying North Shore Community Health Services — Wawa,

📞 Contact the Study Coordinator

Phone: (514) 994-9298

Email: meagan.mooney@mail.mcgill.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All HCV clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗